Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease
Identifieur interne : 000B34 ( Istex/Corpus ); précédent : 000B33; suivant : 000B35Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease
Auteurs : Christine B. Schneider ; Maximilian Pilhatsch ; Martina Rifati ; Wolfgang H. Jost ; Franziska Wodarz ; Georg Ebersbach ; Daniela Djundja ; Gerd Fuchs ; Arne Gies ; Per Odin ; Gerd Reifschneider ; Martin Wolz ; Antonia Bottesi ; Michael Bauer ; Heinz Reichmann ; Alexander StorchSource :
- Movement Disorders [ 0885-3185 ] ; 2010-04-30.
English descriptors
Abstract
Beck depression inventory (BDI‐1A) is the gold standard screening tool for Parkinson's disease (PD) depression, but as a result of its complexity, it is of limited suitability as a quick and easy screening device. We, therefore, validate the 5‐item WHO‐Five Well‐being Index (WHO‐5) as a screening tool for PD depression. Two hundred thirteen of 215 recruited PD patients (99.1%) completed the WHO‐5. Receiver operating characteristic plots were used to calculate sensitivity/specificity for all cut‐off scores for the detection of depression and combined depression/dysthymia as assessed by an independent investigator using the Mini International Neuropsychiatric Interview (MINI). Internal consistency of the WHO‐5 was good (Cronbach's α = 0.83). WHO‐5 showed high validity with adequate detection of depression without differences in the validity indices compared to BDI‐1A (P = 0.234). The optimal cut‐off value for detection of depression was 12 of 13 points. WHO‐5 is a useful, brief, and easy instrument for identifying PD subjects with depression in daily practice. © 2010 Movement Disorder Society
Url:
DOI: 10.1002/mds.22985
Links to Exploration step
ISTEX:67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease</title>
<author><name sortKey="Schneider, Christine B" sort="Schneider, Christine B" uniqKey="Schneider C" first="Christine B." last="Schneider">Christine B. Schneider</name>
<affiliation><mods:affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Pilhatsch, Maximilian" sort="Pilhatsch, Maximilian" uniqKey="Pilhatsch M" first="Maximilian" last="Pilhatsch">Maximilian Pilhatsch</name>
<affiliation><mods:affiliation>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Rifati, Martina" sort="Rifati, Martina" uniqKey="Rifati M" first="Martina" last="Rifati">Martina Rifati</name>
<affiliation><mods:affiliation>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Jost, Wolfgang H" sort="Jost, Wolfgang H" uniqKey="Jost W" first="Wolfgang H." last="Jost">Wolfgang H. Jost</name>
<affiliation><mods:affiliation>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Wodarz, Franziska" sort="Wodarz, Franziska" uniqKey="Wodarz F" first="Franziska" last="Wodarz">Franziska Wodarz</name>
<affiliation><mods:affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Ebersbach, Georg" sort="Ebersbach, Georg" uniqKey="Ebersbach G" first="Georg" last="Ebersbach">Georg Ebersbach</name>
<affiliation><mods:affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Djundja, Daniela" sort="Djundja, Daniela" uniqKey="Djundja D" first="Daniela" last="Djundja">Daniela Djundja</name>
<affiliation><mods:affiliation>Parkinson Clinic Wolfach, Wolfach, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Fuchs, Gerd" sort="Fuchs, Gerd" uniqKey="Fuchs G" first="Gerd" last="Fuchs">Gerd Fuchs</name>
<affiliation><mods:affiliation>Parkinson Clinic Wolfach, Wolfach, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Gies, Arne" sort="Gies, Arne" uniqKey="Gies A" first="Arne" last="Gies">Arne Gies</name>
<affiliation><mods:affiliation>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Odin, Per" sort="Odin, Per" uniqKey="Odin P" first="Per" last="Odin">Per Odin</name>
<affiliation><mods:affiliation>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Reifschneider, Gerd" sort="Reifschneider, Gerd" uniqKey="Reifschneider G" first="Gerd" last="Reifschneider">Gerd Reifschneider</name>
<affiliation><mods:affiliation>Neuro Centrum Odenwald, Erbach, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Wolz, Martin" sort="Wolz, Martin" uniqKey="Wolz M" first="Martin" last="Wolz">Martin Wolz</name>
<affiliation><mods:affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Bottesi, Antonia" sort="Bottesi, Antonia" uniqKey="Bottesi A" first="Antonia" last="Bottesi">Antonia Bottesi</name>
<affiliation><mods:affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Bauer, Michael" sort="Bauer, Michael" uniqKey="Bauer M" first="Michael" last="Bauer">Michael Bauer</name>
<affiliation><mods:affiliation>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Reichmann, Heinz" sort="Reichmann, Heinz" uniqKey="Reichmann H" first="Heinz" last="Reichmann">Heinz Reichmann</name>
<affiliation><mods:affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Storch, Alexander" sort="Storch, Alexander" uniqKey="Storch A" first="Alexander" last="Storch">Alexander Storch</name>
<affiliation><mods:affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1002/mds.22985</idno>
<idno type="url">https://api.istex.fr/document/67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000B34</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease</title>
<author><name sortKey="Schneider, Christine B" sort="Schneider, Christine B" uniqKey="Schneider C" first="Christine B." last="Schneider">Christine B. Schneider</name>
<affiliation><mods:affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Pilhatsch, Maximilian" sort="Pilhatsch, Maximilian" uniqKey="Pilhatsch M" first="Maximilian" last="Pilhatsch">Maximilian Pilhatsch</name>
<affiliation><mods:affiliation>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Rifati, Martina" sort="Rifati, Martina" uniqKey="Rifati M" first="Martina" last="Rifati">Martina Rifati</name>
<affiliation><mods:affiliation>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Jost, Wolfgang H" sort="Jost, Wolfgang H" uniqKey="Jost W" first="Wolfgang H." last="Jost">Wolfgang H. Jost</name>
<affiliation><mods:affiliation>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Wodarz, Franziska" sort="Wodarz, Franziska" uniqKey="Wodarz F" first="Franziska" last="Wodarz">Franziska Wodarz</name>
<affiliation><mods:affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Ebersbach, Georg" sort="Ebersbach, Georg" uniqKey="Ebersbach G" first="Georg" last="Ebersbach">Georg Ebersbach</name>
<affiliation><mods:affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Djundja, Daniela" sort="Djundja, Daniela" uniqKey="Djundja D" first="Daniela" last="Djundja">Daniela Djundja</name>
<affiliation><mods:affiliation>Parkinson Clinic Wolfach, Wolfach, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Fuchs, Gerd" sort="Fuchs, Gerd" uniqKey="Fuchs G" first="Gerd" last="Fuchs">Gerd Fuchs</name>
<affiliation><mods:affiliation>Parkinson Clinic Wolfach, Wolfach, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Gies, Arne" sort="Gies, Arne" uniqKey="Gies A" first="Arne" last="Gies">Arne Gies</name>
<affiliation><mods:affiliation>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Odin, Per" sort="Odin, Per" uniqKey="Odin P" first="Per" last="Odin">Per Odin</name>
<affiliation><mods:affiliation>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Reifschneider, Gerd" sort="Reifschneider, Gerd" uniqKey="Reifschneider G" first="Gerd" last="Reifschneider">Gerd Reifschneider</name>
<affiliation><mods:affiliation>Neuro Centrum Odenwald, Erbach, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Wolz, Martin" sort="Wolz, Martin" uniqKey="Wolz M" first="Martin" last="Wolz">Martin Wolz</name>
<affiliation><mods:affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Bottesi, Antonia" sort="Bottesi, Antonia" uniqKey="Bottesi A" first="Antonia" last="Bottesi">Antonia Bottesi</name>
<affiliation><mods:affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Bauer, Michael" sort="Bauer, Michael" uniqKey="Bauer M" first="Michael" last="Bauer">Michael Bauer</name>
<affiliation><mods:affiliation>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Reichmann, Heinz" sort="Reichmann, Heinz" uniqKey="Reichmann H" first="Heinz" last="Reichmann">Heinz Reichmann</name>
<affiliation><mods:affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Storch, Alexander" sort="Storch, Alexander" uniqKey="Storch A" first="Alexander" last="Storch">Alexander Storch</name>
<affiliation><mods:affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2010-04-30">2010-04-30</date>
<biblScope unit="vol">25</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="777">777</biblScope>
<biblScope unit="page" to="783">783</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2</idno>
<idno type="DOI">10.1002/mds.22985</idno>
<idno type="ArticleID">MDS22985</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>BDI‐1A</term>
<term>Parkinson's disease</term>
<term>WHO‐Five Well‐being Index</term>
<term>depression</term>
<term>screening</term>
<term>validity</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Beck depression inventory (BDI‐1A) is the gold standard screening tool for Parkinson's disease (PD) depression, but as a result of its complexity, it is of limited suitability as a quick and easy screening device. We, therefore, validate the 5‐item WHO‐Five Well‐being Index (WHO‐5) as a screening tool for PD depression. Two hundred thirteen of 215 recruited PD patients (99.1%) completed the WHO‐5. Receiver operating characteristic plots were used to calculate sensitivity/specificity for all cut‐off scores for the detection of depression and combined depression/dysthymia as assessed by an independent investigator using the Mini International Neuropsychiatric Interview (MINI). Internal consistency of the WHO‐5 was good (Cronbach's α = 0.83). WHO‐5 showed high validity with adequate detection of depression without differences in the validity indices compared to BDI‐1A (P = 0.234). The optimal cut‐off value for detection of depression was 12 of 13 points. WHO‐5 is a useful, brief, and easy instrument for identifying PD subjects with depression in daily practice. © 2010 Movement Disorder Society</div>
</front>
</TEI>
<istex><corpusName>wiley</corpusName>
<author><json:item><name>Christine B. Schneider MD</name>
<affiliations><json:string>Department of Neurology, Dresden University of Technology, Dresden, Germany</json:string>
</affiliations>
</json:item>
<json:item><name>Maximilian Pilhatsch MD</name>
<affiliations><json:string>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</json:string>
</affiliations>
</json:item>
<json:item><name>Martina Rifati</name>
<affiliations><json:string>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</json:string>
</affiliations>
</json:item>
<json:item><name>Wolfgang H. Jost MD</name>
<affiliations><json:string>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</json:string>
</affiliations>
</json:item>
<json:item><name>Franziska Wodarz</name>
<affiliations><json:string>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</json:string>
</affiliations>
</json:item>
<json:item><name>Georg Ebersbach MD</name>
<affiliations><json:string>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</json:string>
</affiliations>
</json:item>
<json:item><name>Daniela Djundja</name>
<affiliations><json:string>Parkinson Clinic Wolfach, Wolfach, Germany</json:string>
</affiliations>
</json:item>
<json:item><name>Gerd Fuchs MD</name>
<affiliations><json:string>Parkinson Clinic Wolfach, Wolfach, Germany</json:string>
</affiliations>
</json:item>
<json:item><name>Arne Gies</name>
<affiliations><json:string>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</json:string>
</affiliations>
</json:item>
<json:item><name>Per Odin MD</name>
<affiliations><json:string>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</json:string>
</affiliations>
</json:item>
<json:item><name>Gerd Reifschneider MD</name>
<affiliations><json:string>Neuro Centrum Odenwald, Erbach, Germany</json:string>
</affiliations>
</json:item>
<json:item><name>Martin Wolz MD</name>
<affiliations><json:string>Department of Neurology, Dresden University of Technology, Dresden, Germany</json:string>
</affiliations>
</json:item>
<json:item><name>Antonia Bottesi MD</name>
<affiliations><json:string>Department of Neurology, Dresden University of Technology, Dresden, Germany</json:string>
</affiliations>
</json:item>
<json:item><name>Michael Bauer MD, PhD</name>
<affiliations><json:string>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</json:string>
</affiliations>
</json:item>
<json:item><name>Heinz Reichmann PhD</name>
<affiliations><json:string>Department of Neurology, Dresden University of Technology, Dresden, Germany</json:string>
</affiliations>
</json:item>
<json:item><name>Alexander Storch MD</name>
<affiliations><json:string>Department of Neurology, Dresden University of Technology, Dresden, Germany</json:string>
</affiliations>
</json:item>
</author>
<subject><json:item><lang><json:string>eng</json:string>
</lang>
<value>Parkinson's disease</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>depression</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>WHO‐Five Well‐being Index</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>validity</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>screening</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>BDI‐1A</value>
</json:item>
</subject>
<language><json:string>eng</json:string>
</language>
<abstract>Beck depression inventory (BDI‐1A) is the gold standard screening tool for Parkinson's disease (PD) depression, but as a result of its complexity, it is of limited suitability as a quick and easy screening device. We, therefore, validate the 5‐item WHO‐Five Well‐being Index (WHO‐5) as a screening tool for PD depression. Two hundred thirteen of 215 recruited PD patients (99.1%) completed the WHO‐5. Receiver operating characteristic plots were used to calculate sensitivity/specificity for all cut‐off scores for the detection of depression and combined depression/dysthymia as assessed by an independent investigator using the Mini International Neuropsychiatric Interview (MINI). Internal consistency of the WHO‐5 was good (Cronbach's α = 0.83). WHO‐5 showed high validity with adequate detection of depression without differences in the validity indices compared to BDI‐1A (P = 0.234). The optimal cut‐off value for detection of depression was 12 of 13 points. WHO‐5 is a useful, brief, and easy instrument for identifying PD subjects with depression in daily practice. © 2010 Movement Disorder Society</abstract>
<qualityIndicators><score>6.956</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>612 x 810 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractCharCount>1107</abstractCharCount>
<pdfWordCount>18036</pdfWordCount>
<pdfCharCount>118703</pdfCharCount>
<pdfPageCount>29</pdfPageCount>
<abstractWordCount>163</abstractWordCount>
</qualityIndicators>
<title>Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease</title>
<genre><json:string>Serial article</json:string>
</genre>
<host><volume>25</volume>
<pages><total>7</total>
<last>783</last>
<first>777</first>
</pages>
<issn><json:string>0885-3185</json:string>
</issn>
<issue>6</issue>
<subject><json:item><value>Brief Report</value>
</json:item>
</subject>
<genre></genre>
<language><json:string>unknown</json:string>
</language>
<title>Movement Disorders</title>
<doi><json:string>10.1002/(ISSN)1531-8257</json:string>
</doi>
</host>
<publicationDate>2010</publicationDate>
<copyrightDate>2010</copyrightDate>
<doi><json:string>10.1002/mds.22985</json:string>
</doi>
<id>67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2</id>
<fulltext><json:item><original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2/fulltext/pdf</uri>
</json:item>
<json:item><original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease</title>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<availability><p>Wiley Subscription Services, Inc., A Wiley Company</p>
</availability>
<date>2010</date>
</publicationStmt>
<notesStmt><note type="content">*Potential conflict of interest: Nothing to report.</note>
<note>Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany</note>
</notesStmt>
<sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease</title>
<author><persName><forename type="first">Christine B.</forename>
<surname>Schneider</surname>
<roleName type="degree">MD</roleName>
</persName>
<affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</affiliation>
</author>
<author><persName><forename type="first">Maximilian</forename>
<surname>Pilhatsch</surname>
<roleName type="degree">MD</roleName>
</persName>
<affiliation>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</affiliation>
</author>
<author><persName><forename type="first">Martina</forename>
<surname>Rifati</surname>
</persName>
<affiliation>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</affiliation>
</author>
<author><persName><forename type="first">Wolfgang H.</forename>
<surname>Jost</surname>
<roleName type="degree">MD</roleName>
</persName>
<affiliation>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</affiliation>
</author>
<author><persName><forename type="first">Franziska</forename>
<surname>Wodarz</surname>
</persName>
<affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</affiliation>
</author>
<author><persName><forename type="first">Georg</forename>
<surname>Ebersbach</surname>
<roleName type="degree">MD</roleName>
</persName>
<affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</affiliation>
</author>
<author><persName><forename type="first">Daniela</forename>
<surname>Djundja</surname>
</persName>
<affiliation>Parkinson Clinic Wolfach, Wolfach, Germany</affiliation>
</author>
<author><persName><forename type="first">Gerd</forename>
<surname>Fuchs</surname>
<roleName type="degree">MD</roleName>
</persName>
<affiliation>Parkinson Clinic Wolfach, Wolfach, Germany</affiliation>
</author>
<author><persName><forename type="first">Arne</forename>
<surname>Gies</surname>
</persName>
<affiliation>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</affiliation>
</author>
<author><persName><forename type="first">Per</forename>
<surname>Odin</surname>
<roleName type="degree">MD</roleName>
</persName>
<affiliation>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</affiliation>
</author>
<author><persName><forename type="first">Gerd</forename>
<surname>Reifschneider</surname>
<roleName type="degree">MD</roleName>
</persName>
<affiliation>Neuro Centrum Odenwald, Erbach, Germany</affiliation>
</author>
<author><persName><forename type="first">Martin</forename>
<surname>Wolz</surname>
<roleName type="degree">MD</roleName>
</persName>
<affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</affiliation>
</author>
<author><persName><forename type="first">Antonia</forename>
<surname>Bottesi</surname>
<roleName type="degree">MD</roleName>
</persName>
<affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</affiliation>
</author>
<author><persName><forename type="first">Michael</forename>
<surname>Bauer</surname>
<roleName type="degree">MD, PhD</roleName>
</persName>
<affiliation>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</affiliation>
</author>
<author><persName><forename type="first">Heinz</forename>
<surname>Reichmann</surname>
<roleName type="degree">PhD</roleName>
</persName>
<affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</affiliation>
</author>
<author><persName><forename type="first">Alexander</forename>
<surname>Storch</surname>
<roleName type="degree">MD</roleName>
</persName>
<note type="correspondence"><p>Correspondence: Department of Neurology, Dresden University of Technology, Fetscherstrasse 74, Dresden 01307, Germany</p>
</note>
<affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</affiliation>
</author>
</analytic>
<monogr><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="pISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<idno type="DOI">10.1002/(ISSN)1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2010-04-30"></date>
<biblScope unit="vol">25</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="777">777</biblScope>
<biblScope unit="page" to="783">783</biblScope>
</imprint>
</monogr>
<idno type="istex">67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2</idno>
<idno type="DOI">10.1002/mds.22985</idno>
<idno type="ArticleID">MDS22985</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><creation><date>2010</date>
</creation>
<langUsage><language ident="en">en</language>
</langUsage>
<abstract xml:lang="en"><p>Beck depression inventory (BDI‐1A) is the gold standard screening tool for Parkinson's disease (PD) depression, but as a result of its complexity, it is of limited suitability as a quick and easy screening device. We, therefore, validate the 5‐item WHO‐Five Well‐being Index (WHO‐5) as a screening tool for PD depression. Two hundred thirteen of 215 recruited PD patients (99.1%) completed the WHO‐5. Receiver operating characteristic plots were used to calculate sensitivity/specificity for all cut‐off scores for the detection of depression and combined depression/dysthymia as assessed by an independent investigator using the Mini International Neuropsychiatric Interview (MINI). Internal consistency of the WHO‐5 was good (Cronbach's α = 0.83). WHO‐5 showed high validity with adequate detection of depression without differences in the validity indices compared to BDI‐1A (P = 0.234). The optimal cut‐off value for detection of depression was 12 of 13 points. WHO‐5 is a useful, brief, and easy instrument for identifying PD subjects with depression in daily practice. © 2010 Movement Disorder Society</p>
</abstract>
<textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head>
<item><term>Parkinson's disease</term>
</item>
<item><term>depression</term>
</item>
<item><term>WHO‐Five Well‐being Index</term>
</item>
<item><term>validity</term>
</item>
<item><term>screening</term>
</item>
<item><term>BDI‐1A</term>
</item>
</list>
</keywords>
</textClass>
<textClass><keywords scheme="Journal Subject"><list><head>Article category</head>
<item><term>Brief Report</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc><change when="2009-06-15">Received</change>
<change when="2009-12-04">Registration</change>
<change when="2010-04-30">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName>
<publisherLoc>Hoboken</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1531-8257</doi>
<issn type="print">0885-3185</issn>
<issn type="electronic">1531-8257</issn>
<idGroup><id type="product" value="MDS"></id>
</idGroup>
<titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title>
<title type="short">Mov. Disord.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="60"><doi origin="wiley" registered="yes">10.1002/mds.v25:6</doi>
<numberingGroup><numbering type="journalVolume" number="25">25</numbering>
<numbering type="journalIssue">6</numbering>
</numberingGroup>
<coverDate startDate="2010-04-30">30 April 2010</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="article" position="190" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.22985</doi>
<idGroup><id type="unit" value="MDS22985"></id>
</idGroup>
<countGroup><count type="pageTotal" number="7"></count>
</countGroup>
<titleGroup><title type="articleCategory">Brief Report</title>
<title type="tocHeading1">Brief Reports</title>
</titleGroup>
<copyright ownership="thirdParty">Copyright © 2010 Movement Disorder Society</copyright>
<eventGroup><event type="manuscriptReceived" date="2009-06-15"></event>
<event type="manuscriptRevised" date="2009-12-01"></event>
<event type="manuscriptAccepted" date="2009-12-04"></event>
<event type="firstOnline" date="2010-01-27"></event>
<event type="publishedOnlineFinalForm" date="2010-04-26"></event>
<event type="publishedOnlineAcceptedOrEarlyUnpaginated" date="2010-01-27"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.5.2 mode:FullText" date="2011-08-12"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event>
</eventGroup>
<numberingGroup><numbering type="pageFirst">777</numbering>
<numbering type="pageLast">783</numbering>
</numberingGroup>
<correspondenceTo>Department of Neurology, Dresden University of Technology, Fetscherstrasse 74, Dresden 01307, Germany</correspondenceTo>
<linkGroup><link type="toTypesetVersion" href="file:MDS.MDS22985.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta><countGroup><count type="figureTotal" number="1"></count>
<count type="tableTotal" number="2"></count>
<count type="referenceTotal" number="29"></count>
<count type="wordTotal" number="4924"></count>
</countGroup>
<titleGroup><title type="main" xml:lang="en">Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease<link href="#fn1"></link>
</title>
<title type="short" xml:lang="en">Validation of WHO‐Five in Parkinson's Disease</title>
</titleGroup>
<creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Christine B.</givenNames>
<familyName>Schneider</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Maximilian</givenNames>
<familyName>Pilhatsch</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au3" creatorRole="author" affiliationRef="#af3"><personName><givenNames>Martina</givenNames>
<familyName>Rifati</familyName>
</personName>
</creator>
<creator xml:id="au4" creatorRole="author" affiliationRef="#af3"><personName><givenNames>Wolfgang H.</givenNames>
<familyName>Jost</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au5" creatorRole="author" affiliationRef="#af4"><personName><givenNames>Franziska</givenNames>
<familyName>Wodarz</familyName>
</personName>
</creator>
<creator xml:id="au6" creatorRole="author" affiliationRef="#af4"><personName><givenNames>Georg</givenNames>
<familyName>Ebersbach</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au7" creatorRole="author" affiliationRef="#af5"><personName><givenNames>Daniela</givenNames>
<familyName>Djundja</familyName>
</personName>
</creator>
<creator xml:id="au8" creatorRole="author" affiliationRef="#af5"><personName><givenNames>Gerd</givenNames>
<familyName>Fuchs</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au9" creatorRole="author" affiliationRef="#af6"><personName><givenNames>Arne</givenNames>
<familyName>Gies</familyName>
</personName>
</creator>
<creator xml:id="au10" creatorRole="author" affiliationRef="#af6"><personName><givenNames>Per</givenNames>
<familyName>Odin</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au11" creatorRole="author" affiliationRef="#af7"><personName><givenNames>Gerd</givenNames>
<familyName>Reifschneider</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au12" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Martin</givenNames>
<familyName>Wolz</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au13" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Antonia</givenNames>
<familyName>Bottesi</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au14" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Michael</givenNames>
<familyName>Bauer</familyName>
<degrees>MD, PhD</degrees>
</personName>
</creator>
<creator xml:id="au15" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Heinz</givenNames>
<familyName>Reichmann</familyName>
<degrees>PhD</degrees>
</personName>
</creator>
<creator xml:id="au16" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Alexander</givenNames>
<familyName>Storch</familyName>
<degrees>MD</degrees>
</personName>
<contactDetails><email normalForm="alexander.storch@neuro.med.tu-dresden.de">alexander.storch@neuro.med.tu‐dresden.de</email>
</contactDetails>
</creator>
</creators>
<affiliationGroup><affiliation xml:id="af1" countryCode="DE" type="organization"><unparsedAffiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af2" countryCode="DE" type="organization"><unparsedAffiliation>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af3" countryCode="DE" type="organization"><unparsedAffiliation>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af4" countryCode="DE" type="organization"><unparsedAffiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af5" countryCode="DE" type="organization"><unparsedAffiliation>Parkinson Clinic Wolfach, Wolfach, Germany</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af6" countryCode="DE" type="organization"><unparsedAffiliation>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af7" countryCode="DE" type="organization"><unparsedAffiliation>Neuro Centrum Odenwald, Erbach, Germany</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Parkinson's disease</keyword>
<keyword xml:id="kwd2">depression</keyword>
<keyword xml:id="kwd3">WHO‐Five Well‐being Index</keyword>
<keyword xml:id="kwd4">validity</keyword>
<keyword xml:id="kwd5">screening</keyword>
<keyword xml:id="kwd6">BDI‐1A</keyword>
</keywordGroup>
<fundingInfo><fundingAgency>Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany</fundingAgency>
</fundingInfo>
<supportingInformation><p> Additional Supporting Information may be found in the online version of this article. </p>
</supportingInformation>
<abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title>
<p>Beck depression inventory (BDI‐1A) is the gold standard screening tool for Parkinson's disease (PD) depression, but as a result of its complexity, it is of limited suitability as a quick and easy screening device. We, therefore, validate the 5‐item WHO‐Five Well‐being Index (WHO‐5) as a screening tool for PD depression. Two hundred thirteen of 215 recruited PD patients (99.1%) completed the WHO‐5. Receiver operating characteristic plots were used to calculate sensitivity/specificity for all cut‐off scores for the detection of depression and combined depression/dysthymia as assessed by an independent investigator using the Mini International Neuropsychiatric Interview (MINI). Internal consistency of the WHO‐5 was good (Cronbach's α = 0.83). WHO‐5 showed high validity with adequate detection of depression without differences in the validity indices compared to BDI‐1A (<i>P</i>
= 0.234). The optimal cut‐off value for detection of depression was 12 of 13 points. WHO‐5 is a useful, brief, and easy instrument for identifying PD subjects with depression in daily practice. © 2010 Movement Disorder Society</p>
</abstract>
</abstractGroup>
</contentMeta>
<noteGroup><note xml:id="fn1"><p>Potential conflict of interest: Nothing to report.</p>
</note>
</noteGroup>
</header>
</component>
</istex:document>
</istex:metadataXml>
<!--Version 0.6 générée le 4-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en"><title>Validation of WHO‐Five in Parkinson's Disease</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en"><title>Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease</title>
</titleInfo>
<name type="personal"><namePart type="given">Christine B.</namePart>
<namePart type="family">Schneider</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Maximilian</namePart>
<namePart type="family">Pilhatsch</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Martina</namePart>
<namePart type="family">Rifati</namePart>
<affiliation>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Wolfgang H.</namePart>
<namePart type="family">Jost</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Franziska</namePart>
<namePart type="family">Wodarz</namePart>
<affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Georg</namePart>
<namePart type="family">Ebersbach</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Movement Disorders Clinic, Beelitz‐Heilstätten, Germany</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Daniela</namePart>
<namePart type="family">Djundja</namePart>
<affiliation>Parkinson Clinic Wolfach, Wolfach, Germany</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Gerd</namePart>
<namePart type="family">Fuchs</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Parkinson Clinic Wolfach, Wolfach, Germany</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Arne</namePart>
<namePart type="family">Gies</namePart>
<affiliation>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Per</namePart>
<namePart type="family">Odin</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology, Zentralkrankenhaus Reinkenheide, Bremerhaven, Germany</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Gerd</namePart>
<namePart type="family">Reifschneider</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Neuro Centrum Odenwald, Erbach, Germany</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Martin</namePart>
<namePart type="family">Wolz</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Antonia</namePart>
<namePart type="family">Bottesi</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Michael</namePart>
<namePart type="family">Bauer</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>Department of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Heinz</namePart>
<namePart type="family">Reichmann</namePart>
<namePart type="termsOfAddress">PhD</namePart>
<affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Alexander</namePart>
<namePart type="family">Storch</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology, Dresden University of Technology, Dresden, Germany</affiliation>
<description>Correspondence: Department of Neurology, Dresden University of Technology, Fetscherstrasse 74, Dresden 01307, Germany</description>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre authority="originalCategForm">article</genre>
<originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<place><placeTerm type="text">Hoboken</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2010-04-30</dateIssued>
<dateCaptured encoding="w3cdtf">2009-06-15</dateCaptured>
<dateValid encoding="w3cdtf">2009-12-04</dateValid>
<copyrightDate encoding="w3cdtf">2010</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription><internetMediaType>text/html</internetMediaType>
<extent unit="figures">1</extent>
<extent unit="tables">2</extent>
<extent unit="references">29</extent>
<extent unit="words">4924</extent>
</physicalDescription>
<abstract lang="en">Beck depression inventory (BDI‐1A) is the gold standard screening tool for Parkinson's disease (PD) depression, but as a result of its complexity, it is of limited suitability as a quick and easy screening device. We, therefore, validate the 5‐item WHO‐Five Well‐being Index (WHO‐5) as a screening tool for PD depression. Two hundred thirteen of 215 recruited PD patients (99.1%) completed the WHO‐5. Receiver operating characteristic plots were used to calculate sensitivity/specificity for all cut‐off scores for the detection of depression and combined depression/dysthymia as assessed by an independent investigator using the Mini International Neuropsychiatric Interview (MINI). Internal consistency of the WHO‐5 was good (Cronbach's α = 0.83). WHO‐5 showed high validity with adequate detection of depression without differences in the validity indices compared to BDI‐1A (P = 0.234). The optimal cut‐off value for detection of depression was 12 of 13 points. WHO‐5 is a useful, brief, and easy instrument for identifying PD subjects with depression in daily practice. © 2010 Movement Disorder Society</abstract>
<note type="content">*Potential conflict of interest: Nothing to report.</note>
<note type="funding">Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany</note>
<subject lang="en"><genre>Keywords</genre>
<topic>Parkinson's disease</topic>
<topic>depression</topic>
<topic>WHO‐Five Well‐being Index</topic>
<topic>validity</topic>
<topic>screening</topic>
<topic>BDI‐1A</topic>
</subject>
<relatedItem type="host"><titleInfo><title>Movement Disorders</title>
</titleInfo>
<titleInfo type="abbreviated"><title>Mov. Disord.</title>
</titleInfo>
<note type="content"> Additional Supporting Information may be found in the online version of this article.</note>
<subject><genre>article category</genre>
<topic>Brief Report</topic>
</subject>
<identifier type="ISSN">0885-3185</identifier>
<identifier type="eISSN">1531-8257</identifier>
<identifier type="DOI">10.1002/(ISSN)1531-8257</identifier>
<identifier type="PublisherID">MDS</identifier>
<part><date>2010</date>
<detail type="volume"><caption>vol.</caption>
<number>25</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>6</number>
</detail>
<extent unit="pages"><start>777</start>
<end>783</end>
<total>7</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2</identifier>
<identifier type="DOI">10.1002/mds.22985</identifier>
<identifier type="ArticleID">MDS22985</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 2010 Movement Disorder Society</accessCondition>
<recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin>
<recordContentSource>WILEY</recordContentSource>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B34 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000B34 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Istex |étape= Corpus |type= RBID |clé= ISTEX:67EDBE78549E3FC8DEE96F5654F33F0C6655D5F2 |texte= Utility of the WHO‐five well‐being index as a screening tool for depression in Parkinson's disease }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |